REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2026
Back to search
Official data from USPTO
STOKE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STOKE THERAPEUTICS
ST13
US500000087043362Class
42
Filing
87043362
Registration
5262266
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
08/08/2026
Trademark type
Word
Nice classes
42
Filing date
05/19/2016
Registration date
08/08/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/17/2024
Last transaction
08/08/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/04/2016
First use in commerce
10/04/2016
Drawing code
4
Owner type
03
Owner location
Bedford, MA, US
Examiner
GOLD, BARBARA
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Stoke Therapeutics, Inc.
Representatives
Karen A. Webb, Esq. FENWICK & WEST LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of bioscience
Publications
History of USPTO decisions and trademark events.
27 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/17/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/17/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/24/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/08/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
06/04/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/07/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/01/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/30/2017
IUAF
USE AMENDMENT FILED
06/05/2017
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/27/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2016
PUBO
PUBLISHED FOR OPPOSITION
11/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/10/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/10/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/10/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/10/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/10/2016
DOCK
ASSIGNED TO EXAMINER
09/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2016
NWAP
NEW APPLICATION ENTERED
05/23/2016
Continuous trademark protection
Get notified about every new filing that threatens STOKE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.